胶质肉瘤
免疫组织化学
成纤维细胞活化蛋白
胶质母细胞瘤
病理
医学
癌症研究
成纤维细胞
癌症
生物
内科学
细胞培养
遗传学
作者
Christoph Oster,Lukas Kessler,Tobias Blau,Kathy Keyvani,Kim M. Pabst,Wolfgang P. Fendler,Pedro Fragoso Costa,Lazaros Lazaridis,Teresa Schmidt,Jonas Feldheim,Daniela Pierscianek,Hans–Ulrich Schildhaus,Ulrich Sure,Yahya Ahmadipour,Christoph Kleinschnitz,Nika Guberina,Martin Stuschke,Cornelius Deuschl,Björn Scheffler,Ken Herrmann,Sied Kebir,Martin Glas
标识
DOI:10.2967/jnumed.123.267151
摘要
Despite their unique histologic features, gliosarcomas belong to the group of glioblastomas and are treated according to the same standards. Fibroblast activation protein (FAP) is a component of a tumor-specific subpopulation of fibroblasts that plays a critical role in tumor growth and invasion. Some case studies suggest an elevated expression of FAP in glioblastoma and a particularly strong expression in gliosarcoma attributed to traits of predominant mesenchymal differentiation. However, the prognostic impact of FAP and its diagnostic and therapeutic potential remain unclear. Here, we investigate the clinical relevance of FAP expression in gliosarcoma and glioblastoma and how it correlates with
科研通智能强力驱动
Strongly Powered by AbleSci AI